Company & Sponsor Intelligence

George Washington University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed2

Countries2

Therapeutic footprint

alzheimersdepressionschizophrenia

Indexed studies

NCT00786318Ziprasidone vs Standard Therapy for Agitated Patients in the ED
schizophrenia · United StatesPHASE4

NCT04282915Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT)
depression · NepalNA

NCT06039267Brain Health & the Microbiome
alzheimers · United StatesCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →